Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma

Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using self report methods. Researchers hypothesized that a significant number of recipients would report a decrease in their symptoms and general satisfaction with the treatment they received.

Study Overview

• Status: Completed
• Conditions: Healthy
• Intervention / Treatment: Behavioral: Crisis intervention

Detailed Description

Researchers conducted a follow-up study of clients of Meytiv, the clinical branch of the Jerusalem Center for the Treatment of Psychotrauma. Researchers plan to use the results of the study to better understand the demographics of those who come to the Center, and to improve the services offered to our clients. Before beginning treatment, every Meytiv client filled out a questionnaire in which information is requested regarding demographics, trauma history, symptoms, and various levels of functioning. Researchers administered a similar self-report questionnaire to all clients upon completion of treatment. The follow-up questionnaire contained the following several indices: the Traumatic Events Screening Inventory (TESI), which requests a client's trauma history; the Multidimensional Scale of Perceived Social Support, which measures level of family, friend, and other support; the Brief Symptom Inventory, which measures level of various psychiatric symptoms, including somatic complaints, depressive symptoms, anxiety, and paranoid or hostile thoughts; the Self-Efficacy Scale, which measures level of self-reliance and confidence in one's ability to cope with stressors; and PDS, which measures subjective response to trauma, symptoms, and and level of functioning. This questionnaire, which mirrors one completed by all Meytiv's clients before treatment, was administered to those clients who completed treatment within a year of the study. Clients completed the follow-up questionnaire on condition that if they were in need of further treatment, Meytiv would refer them to the appropriate provider. Responses will be coded and analyzed to check significance among potentially related variables, including demographic variables. Most importantly, results of the follow-up questionnaire will be compared to its parallel from the beginning of treatment in order to examine what effects our treatment has on one's symptoms, and whether our clients have been satisfied

• Study Type: Observational
• Enrollment (Actual): 100

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 12 years and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year

Description

Inclusion Criteria:

• All clients who were exposed to a traumatic event within the last 2 years and completed treatment at the Trauma Center within the last year

Exclusion Criteria:

• Clients under the age of 12

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
depressive symptoms, anxiety, PDS, which measures subjective response to trauma, symptoms, and and level of functioning.	April 2007- March 2008

Secondary Outcome Measures

Outcome Measure	Time Frame
level of family, friend, and other support, Self-Efficacy Scale	Aprol 2007- March2008

Other Outcome Measures

Outcome Measure	Time Frame
Traumatic Events Screening Inventory (TESI)	April 2008- March 2008

Collaborators and Investigators

• Sponsor: Herzog Hospital
• Investigators: Principal Investigator: Danny Brom, Ph.D, Israel Center for the Treatment of Psychotrauma

Study record dates

Study Major Dates

• Study Start: April 1, 2007
• Primary Completion (Actual): March 1, 2008
• Study Completion (Actual): March 1, 2008

Study Registration Dates

• First Submitted: April 19, 2007
• First Submitted That Met QC Criteria: April 19, 2007
• First Posted (Estimate): April 20, 2007

Study Record Updates

• Last Update Posted (Estimate): September 4, 2013
• Last Update Submitted That Met QC Criteria: September 3, 2013
• Last Verified: September 1, 2013

More Information

Terms related to this study

• Keywords: perceived increase or decrease in symptoms post treatment; Satisfaction with the treatment
• Other Study ID Numbers: Brom3CTIL